Most Popular Stories
- CDC: H1N1 cases down in some parts of U.S.
- Initial 'meaningful use' standards to be simple, as deadline is in sight
- Groups recommend less prevention for breast, cervical cancer screenings
- Conservatives on Hill say individual mandate is unconstitutional
- Disparity researchers still stumped on colon cancer outcome differences
- Open-source EMR opens doors to quality care
Featured Jobs
-
Family Practice Job for Indiana
StaffPointe, LLC - north, IN -
PICU RN Job in Texas
StaffPointe, LLC - near Galveston, TX -
Orthopedic Surgeon Job in Washington
StaffPointe, LLC - near Seattle, WA -
Director of Billing & Collections
Pharma-Cruiting Life Sciences Executive Search - New York, NY -
Ambulatory Surgery Mgr Job in Arizona
StaffPointe, LLC - confidential, AZ
Events
- Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT - Harvard Business School 7th Healthcare Conference
January 30, 2010
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- health reform
- prescription drugs
- pharmaceutical companies
FDA control of tobacco approved by Senate
The Senate approved legislation last week to give the Food and Drug Administration control over, not only the ingredients that go into tobacco products, but also marketing and advertising of such products, according to the Los Angeles Times. This ruling comes only months after Congress approved the biggest increase to the federal cigarette tax to date--62 cents--in an effort to curb smoking in the United States.
Illinois Sen. Dick Durban said this likely spells the end of iconic tobacco characters like Joe Camel. The measure passed 79-17, with all but one of those 17 being Republicans. The marketing of "light cigarettes" would also be banned under this legislation.
"This bill is the strongest anti-tobacco measure the Congress of the United States has ever passed," said Matthew Myers, president of the Campaign for Tobacco Free Kids. "Its breadth would have been unimaginable five years ago."
Oddly enough, it was only about two weeks ago that the New England Journal of Medicine reported several U.S., Canadian and U.K.-based insurance companies have large amounts of stock invested in tobacco companies.
"Despite calls upon the insurance industry to get out of the tobacco business by physicians and others, insurers continue to put their profits above people's health," said J. Wesley Boyd, an assistant clinical professor of psychiatry at Harvard Medical School.
For more info:
- here's the full Los Angeles Times article
Related Articles:
Tobacco giants funding MA universities research
Cigarette company funded cancer study
More states may raise tobacco taxes
Related Stories
- SPOTLIGHT: Study: Last-minute drug approvals less safe
- FDA says Glaxo didn't report Avandia data
- ALSO NOTED: Revenue growth slows for PA hospitals, but they remain profitable; JAMA rips journal use for off-label pharma marke
- Study: Social networks can have impact on health behavior
- Avandia gets black-box warning
- Researcher challenges FDA approval process
- Direct-to-consumer pharma ads questioned
- FDA panel votes to keep Avandia on the market
- Study: When uninsured get Medicare, it's costly
- SPOTLIGHT: New England Journal editor talks reform
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





